Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Orchid Pharma Limited · Formerly Orchid Chemicals & Pharmaceuticals · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993 on BSE, Jul 2010 on NSE
Last close ₹836.45down ₹56.95 (6.37%)BSE ₹833.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
52-week range of traded prices to 30 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma board and management
34 filed, newest first.
Jun 2025
Jul 2024
17 Jul · Management
May 2024
Apr 2024
12 Apr · Management
Dec 2023
Oct 2023
20 Oct · Management
Feb 2023
1 Feb · Management
Nov 2022
Jul 2022
Apr 2020
6 Apr · Management
Jan 2018
Dec 2017
14 Dec · Management
Jun 2017
30 Jun · Management
Jun 2016
Jan 2016
Jun 2015
Mar 2015
Nov 2014
Mar 2014
Aug 2013
14 Aug · Management
Prof. Bala V Balachandran has resigned from the Board of the Company and Shri Sundaram Yuvaraj has been inducted into the Board of Orchid Chemicals and Phamaceuticals Limited with effect from August 14, 2013.
Nov 2012
27 Nov · Management
Shri Bharat D Shah and Shri Deepak Vaidya, Directors have resigned from the Board of the Company with effect from November 15, 2012 and November 19, 2012 respectively.
May 2011
24 May · Management
Mr. Bala V Balachandran has been inducted into the Board of Orchid as Additional Director with effect from May 18, 2011. The appointment has been approved by the Board at its meeting held on May 18, 2011.
Jan 2011
19 Jan · Management
Mr. R. Sankaran and Mr. Bharat Shah have been inducted into the Board of Orchid as Additional Directors with effect from January 19, 2011. Their appointments have been approved by the Board at its meeting held on January 19, 2011.
Oct 2010
28 Oct · Management
Shri R. Narayanan, Chairman has resigned on October 28, 2010 from the Board of Orchid, given his health condition and age. Subsequent to his resignation, Shri K. Raghavendra Rao, Managing Director has been appointed as the Chairman and Managing Director. Mr.Deepak Vaidya who has been on the Board as a nominee of Symphony Capital Partners (Asia) Pte Ltd will continue to be on the Board as an Independent director subsequent to the sale by Symphony Capital Partners (Asia) Pte Ltd. of their shareholding in Orchid. The above has been approved by the Board of Directors of the Company at its meeting held on October 28, 2010.19 Oct · Management
Shri. Anil Thadani has resigned from the Board of the Orchid Chemicals & Pharmaceuticals Limited with effect from September 28, 2010. Subsequent to his resignation, Shri. Rajgopal Rajkumar, Alternate Director to Shri. Anil Thadani, also vacates the office of Directorship with effect from September 28, 2010.
Apr 2010
28 Apr · Management
Mr. S Krishnan, Head-Finance & Business Planning has been inducted into the Board of Orchid as Executive Director with effect from April 28, 2010. The appointment has been approved by the Board at its Meeting held on April 28, 2010.
Mar 2010
31 Mar · Management
Dr. C. Bhaktavatsala Rao, who has been associated with Orchid from the inception as a member of the Board and subsequently appointed as Deputy Managing Director has resigned from the services of the Company on March 29, 2010. He has been relieved from the Board / services of Orchid
Oct 2008
14 Oct · Management
Dr Anzaghi Piergiorgio, Director has resigned from the Board of Orchid Chemicals & Pharmaceuticals Limited with effect from October 3, 2008
Sep 2008
24 Sep · Management
Industrial Development Bank of India has withdrawn the nomination of Shri S Andi and instead appointed Shri S Jeyakumar, General Manager, Infrastructure Corporate Group, Industrial Development Bank of India Limited, Mumbai as its nominee on the Board of Orchid Chemicals & Pharmaceuticals Limited with effect from September 08, 2008
Feb 2008
6 Feb · Management
Dr Bishwajit Nag, Director has resigned from the Board of Orchid Chemicals & Pharmaceuticals Limited with effect from February 04, 2008